Related references
Note: Only part of the references are listed.Treatment with the glutamate modulator riluzole prevents early life stress-induced cognitive deficits and impairments in synaptic plasticity in APPswe/PS1dE9 mice
Sylvie L. Lesuis et al.
NEUROPHARMACOLOGY (2019)
Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology
Joana Margarida Silva et al.
CELL DEATH AND DIFFERENTIATION (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Early life stress impairs fear memory and synaptic plasticity; a potential role for GluN2B
Sylvie L. Lesuis et al.
NEUROPHARMACOLOGY (2019)
Amyloid-beta oligomers suppress subunit-specific glutamate receptor increase during LTP
Hiromitsu Tanaka et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms
Katy Bernard et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease
David Baglietto-Vargas et al.
AGING CELL (2018)
Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
Joseph McInnes et al.
NEURON (2018)
Endolysosomal degradation of Tau and its role in glucocorticoid-driven hippocampal malfunction
Joao Vaz-Silva et al.
EMBO JOURNAL (2018)
Environmental Enrichment Improves Cognitive Deficits, AD Hallmarks and Epigenetic Alterations Presented in 5xFAD Mouse Model
Christian Grinan-Ferre et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice
Albert Giralt et al.
NEUROPHARMACOLOGY (2017)
Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats
Francesca Calabrese et al.
PHARMACOLOGICAL RESEARCH (2017)
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Atul Bhardwaj et al.
NATURE COMMUNICATIONS (2017)
Noradrenergic Modulation of Cognition in Health and Disease
Olga Borodovitsyna et al.
NEURAL PLASTICITY (2017)
Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors
Sylvie Bretin et al.
PLOS ONE (2017)
Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity
Takashi Miyamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Tau Mislocation in Glucocorticoid-Triggered Hippocampal Pathology
Sara Pinheiro et al.
MOLECULAR NEUROBIOLOGY (2016)
Tau as the Converging Protein between Chronic Stress and Alzheimer's Disease Synaptic Pathology
Ioannis Sotiropoulos et al.
NEURODEGENERATIVE DISEASES (2016)
Gamma frequency entrainment attenuates amyloid load and modifies microglia
Hannah F. Iaccarino et al.
NATURE (2016)
Tau protein is essential for stress-induced brain pathology
Sofia Lopes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3
Niels R. Reinders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
THE SEROTONERGIC SYSTEM AND COGNITIVE FUNCTION
Dubravka Svob Strac et al.
TRANSLATIONAL NEUROSCIENCE (2016)
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology of Alzheimer's Disease
Carolyn C. Rudy et al.
AGING AND DISEASE (2015)
Female Hippocampus Vulnerability to Environmental Stress, a Precipitating Factor in Tau Aggregation Pathology
Ioannis Sotiropoulos et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease
Nicole C. Berchtold et al.
NEUROBIOLOGY OF AGING (2014)
The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials
Reisa Sperling et al.
NEURON (2014)
Functional Insights from Glutamate Receptor Ion Channel Structures
Janesh Kumar et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
The Slow Afterhyperpolarization: A Target of β1-Adrenergic Signaling in Hippocampus-Dependent Memory Retrieval
Lei Zhang et al.
JOURNAL OF NEUROSCIENCE (2013)
The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome System
Hwan-Ching Tai et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Hyo Jung Kang et al.
NATURE MEDICINE (2012)
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Maurizio Popoli et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease
Michael W. Weiner et al.
ALZHEIMERS & DEMENTIA (2011)
Dendritic Degeneration, Neurovascular Defects, and Inflammation Precede Neuronal Loss in a Mouse Model for Tau-Mediated Neurodegeneration
Tomasz Jaworski et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Stress Acts Cumulatively To Precipitate Alzheimer's Disease-Like Tau Pathology and Cognitive Deficits
Ioannis Sotiropoulos et al.
JOURNAL OF NEUROSCIENCE (2011)
Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1
Damian Refojo et al.
SCIENCE (2011)
Neuropathological Alterations in Alzheimer Disease
Alberto Serrano-Pozo et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
S 18986: A Positive Allosteric Modulator of AMPA-Type Glutamate Receptors Pharmacological Profile of a Novel Cognitive Enhancer
Katy Bernard et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers
Helena Decker et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation
Hai-Yan Wu et al.
JOURNAL OF NEUROSCIENCE (2010)
Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Hans Zempel et al.
JOURNAL OF NEUROSCIENCE (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Psychological Distress and Risk for Dementia
Martine Simard et al.
CURRENT PSYCHIATRY REPORTS (2009)
The amyloidogenic potential and behavioral correlates of stress
C. Catania et al.
MOLECULAR PSYCHIATRY (2009)
Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease?
Enrico Mossello et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Stress and glucocorticoid footprints in the brain - The path from depression to Alzheimer's disease
I. Sotiropoulos et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss
Helen Hsieh et al.
NEURON (2006)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Stephen W. Scheff et al.
NEUROBIOLOGY OF AGING (2006)
Ampakines and the threefold path to cognitive enhancement
Gary Lynch et al.
TRENDS IN NEUROSCIENCES (2006)
Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer's disease
Kim N. Green et al.
JOURNAL OF NEUROSCIENCE (2006)
Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model
Yun Ha Jeong et al.
FASEB JOURNAL (2006)
Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease
E Elgh et al.
BIOLOGICAL PSYCHIATRY (2006)
Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake
CH Yang et al.
JOURNAL OF NEUROSCIENCE (2005)
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data
MD Black
PSYCHOPHARMACOLOGY (2005)
SRC kinases: A hub for NMDA receptor regulation
MW Salter et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Automatic recognition of explorative strategies in the Morris water maze
A Graziano et al.
JOURNAL OF NEUROSCIENCE METHODS (2003)
Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease
MKP Lai et al.
NEUROREPORT (2002)
Share Paper
